The City of Cape Town invites applications for Stage 1 (Request for Qualification) to procure a private party to undertake the financing, design, construction, operation, and maintenance of the Faure New Water Scheme via a Public-Private Partnership (PPP).
The University of Cape Town leads the Mitigating Antimalarial Resistance Consortium for South-East Africa (MARC SE-Africa) research program funded under the EU Horizon scheme. The initiative brings together clinical researchers, health policy experts, and national malaria programmes to improve antimalarial drug resistance surveillance, build predictive maps across 18 South-East African countries, co-design costed regional action plans, and translate evidence into updated treatment guidelines using MAGICapp.
Stellenbosch University, as part of an African and European research consortium under the EDCTP3 / Horizon Europe program, is implementing the GenPath Africa project. The initiative aims to strengthen genomic epidemiology and public health surveillance across Southern and East Africa, focusing on drug-resistant HIV-1 and Tuberculosis, wastewater and One Health surveillance, degree training in South Africa, and technology transfer to the National Public Health Institute of Mozambique.
The Biologicals and Vaccines Institute of Southern Africa (Biovac) is expanding its biopharmaceutical manufacturing footprint in Cape Town through a multi-vaccine project. The initiative includes technology transfer agreements for vaccine fill and finish manufacturing as well as the end-to-end scale-up of an internally developed Oral Cholera Vaccine (OCV). The project involves constructing a new green facility designed to manufacture up to 250 million vaccine doses per year, comprising a glass vial fill & finish suite, a drug substance suite for inactivated OCV, and a blow-fill-seal plastic line for fill & finish.
The Biologicals and Vaccines Institute of Southern Africa (Biovac), supported by IFC financing, is establishing a new vaccine manufacturing facility adjacent to its Cape Town operations. The project entails constructing a facility with a glass vial fill-and-finish suite, drug substance suite, and blow-fill-seal plastic line for producing vaccines including Pneumococcal Conjugate Vaccine (PCV), Meningococcal Vaccine (Mening-X), Inactivated Polio Vaccine (IPV), Oral Cholera Vaccine (OCV), and Rotavirus Vaccine.
FirstRand Bank Limited (FRB) is issuing a senior unsecured outcome-based bond of up to ZAR 1.6 billion with IFC as the anchor investor. The bond proceeds are dedicated to on-lending to agricultural micro, small, and medium enterprises (MSMEs) in South Africa, while funding an outcome-based conservation project focused on removing invasive plant species for ecological restoration of water yield in the Wemmershoek, Steenbras, and Berg River catchments.
Western Cape tenders come from the provincial departments, the City of Cape Town, district municipalities such as Cape Winelands and Garden Route, local municipalities, SOEs, universities and a strong private sector. The City of Cape Town is one of the largest single buyers in the country, and opportunities span construction, professional services, IT, security, cleaning and more.
